Hunan Hansen Pharmaceutical Co Ltd
Hunan Hansen Pharmaceutical Co., Ltd. engages in the production and sale of traditional Chinese preparations in China and internationally. The company offers digestive system medicines; cardiovascular and cerebrovascular medicines; kidney-tonifying and urine-reducing medicines; trauma medicines; diagnostic medicines, etc. It provides medicines in injection, mixture, tablet, capsule, granule, syru… Read more
Hunan Hansen Pharmaceutical Co Ltd (002412) - Total Liabilities
Latest total liabilities as of September 2025: CN¥301.66 Million CNY
Based on the latest financial reports, Hunan Hansen Pharmaceutical Co Ltd (002412) has total liabilities worth CN¥301.66 Million CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Hunan Hansen Pharmaceutical Co Ltd - Total Liabilities Trend (2006–2024)
This chart illustrates how Hunan Hansen Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Hunan Hansen Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Hunan Hansen Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Dr. Hönle AG
OTCGREY:DRHNF
|
USA | $68.48 Million |
|
thyssenkrupp nucera AG & Co. KGaA
OTCGREY:THYKF
|
USA | $384.00 Million |
|
Hyliion Holdings Corp.
NYSE MKT:HYLN
|
USA | $12.38 Million |
|
Rainbow Tours SA
WAR:RBW
|
Poland | zł910.82 Million |
|
Hubei Mailyard Share Co Ltd
SHG:600107
|
China | CN¥289.08 Million |
|
Cabio Biotech Wuhan Co Ltd
SHG:688089
|
China | CN¥183.42 Million |
|
Fox-Wizel Ltd
PINK:FXWZF
|
USA | $7.38 Billion |
|
TRANSILVANIA INVESTMENTS ALLIANCE S.A.
RO:TRANSI
|
Romania | RON160.02 Million |
Liability Composition Analysis (2006–2024)
This chart breaks down Hunan Hansen Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.49 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.13 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Hunan Hansen Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Hunan Hansen Pharmaceutical Co Ltd (2006–2024)
The table below shows the annual total liabilities of Hunan Hansen Pharmaceutical Co Ltd from 2006 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥343.85 Million | -7.93% |
| 2023-12-31 | CN¥373.46 Million | -5.89% |
| 2022-12-31 | CN¥396.81 Million | +7.54% |
| 2021-12-31 | CN¥368.99 Million | +25.54% |
| 2020-12-31 | CN¥293.92 Million | -16.72% |
| 2019-12-31 | CN¥352.93 Million | -18.87% |
| 2018-12-31 | CN¥435.02 Million | -9.59% |
| 2017-12-31 | CN¥481.18 Million | +15.70% |
| 2016-12-31 | CN¥415.88 Million | +227.90% |
| 2015-12-31 | CN¥126.83 Million | -40.89% |
| 2014-12-31 | CN¥214.59 Million | +0.06% |
| 2013-12-31 | CN¥214.46 Million | +179.39% |
| 2012-12-31 | CN¥76.76 Million | +39.70% |
| 2011-12-31 | CN¥54.95 Million | +11.61% |
| 2010-12-31 | CN¥49.23 Million | -27.27% |
| 2009-12-31 | CN¥67.69 Million | -20.06% |
| 2008-12-31 | CN¥84.67 Million | -2.11% |
| 2007-12-31 | CN¥86.49 Million | -40.13% |
| 2006-12-31 | CN¥144.46 Million | -- |